MMS

Maximus, Inc.

69
Fundamentals61/ 100
Valuation85/ 100
Upside potential68/ 100
Risk potential13/ 100

MMS has the edge over RKLB overall, supported by stronger valuation and lower modeled downside.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

MMS Fundamentals

MetricStatus
Stable
Healthy
Healthy
Unavailable

MMS's profitability and cash flow are currently healthy, and its revenue is stable. There isn't enough data to rate its balance sheet.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

MMS PE Valuation

CHEAPFAIREXPENSIVE8.4x17x25x34x
CHEAPFAIREXPENSIVE8.4x17x25x34x
LevelPEPriceVs current
Forward7.4x$64.87—
Current9.7x$64.87—
Cheap15x$97.91+51%
Fair19x$128+98%
Expensive26x$176+171%

Historical ranges are pointers, not guarantees.

MMS's PE is in its cheap range at 9.7x. If earnings grow as analysts expect, today's price would be 7.4x next year's earnings.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

MMS Forward outlook

MetricOutlook
Strongly improving
Growth
Stable
Improving
Limited
High

Analysts expect MMS's earnings to grow and its profitability to improve, with its revenue holding steady.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

RKLB has the edge over MMS on the outlook, with more favorable revenue expectations.

MMS Risk to reward

ScenarioChangePrice
Upside+27%$82.40
Downside-13%$56.45

Calculated from the latest close: $64.87 on Nov 12.

MMS has a better modeled risk to reward balance than RKLB, with more potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB trails MMS on modeled risk to reward, with less potential upside relative to its potential downside.

MMS Earnings Per Share

Q3 2023: $2.63Q4 2023: $3.02Q1 2024: $3.81Q2 2024: $4.77Q3 2024: $4.99Q4 2024: $4.64Q1 2025: $5.02Q2 2025: $5.42Q3 2025: $5.51Q4 2025: $6.52Q1 2026: $6.63Q2 2026: $6.72Forward: $8.77
Q3 2023: $2.63Q4 2023: $3.02Q1 2024: $3.81Q2 2024: $4.77Q3 2024: $4.99Q4 2024: $4.64Q1 2025: $5.02Q2 2025: $5.42Q3 2025: $5.51Q4 2025: $6.52Q1 2026: $6.63Q2 2026: $6.72Forward: $8.77
QuarterTTM EPSYoY
Forward$8.77+31%
Q2 2026$6.72+24%
Q1 2026$6.63+32%
Q4 2025$6.52+41%
Q3 2025$5.51+10%
Q2 2025$5.42+14%
Q1 2025$5.02+32%
Q4 2024$4.64+54%
Q3 2024$4.99+90%

MMS has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

MMS Quarterly Revenue

Q3 2023: $1.3BQ4 2023: $1.3BQ1 2024: $1.3BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.4BQ2 2025: $1.3BQ3 2025: $1.3BQ4 2025: $1.3BQ1 2026: $1.3BQ2 2026: $1.3B
Q3 2023: $1.3BQ4 2023: $1.3BQ1 2024: $1.3BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.4BQ1 2025: $1.4BQ2 2025: $1.3BQ3 2025: $1.3BQ4 2025: $1.3BQ1 2026: $1.3BQ2 2026: $1.3B
QuarterRevenueYoY
Q2 2026$1.3B-5.1%
Q1 2026$1.3B-4.1%
Q4 2025$1.3B-4.1%
Q3 2025$1.3B+0.2%
Q2 2025$1.3B+2.5%
Q1 2025$1.4B+1%
Q4 2024$1.4B+5.7%
Q3 2024$1.3B+4.4%

MMS's revenue grew through 2023 and has held roughly level since: $1.3B last quarter, down 5.1% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over MMS on sales, with more consistent year-over-year improvement.

MMS Free Cash Flow

Q3 2023: $113MQ4 2023: −$639,000Q1 2024: $105MQ2 2024: $165MQ3 2024: $132MQ4 2024: −$103MQ1 2025: $26MQ2 2025: −$198MQ3 2025: $642MQ4 2025: −$251MQ1 2026: $179MQ2 2026: −$137M
Q3 2023: $113MQ4 2023: −$639,000Q1 2024: $105MQ2 2024: $165MQ3 2024: $132MQ4 2024: −$103MQ1 2025: $26MQ2 2025: −$198MQ3 2025: $642MQ4 2025: −$251MQ1 2026: $179MQ2 2026: −$137M
QuarterFree cash flowYoY
Q2 2026-$137M+$61.2M
Q1 2026$179M+602%
Q4 2025-$250.7M-$147.7M
Q3 2025$641.8M+387%
Q2 2025-$198.2M-220%
Q1 2025$25.5M-76%
Q4 2024-$103M-$102.3M
Q3 2024$131.9M+17%

MMS has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

MMS Total Shares

Q3 2023: 61MQ4 2023: 62MQ1 2024: 62MQ2 2024: 61MQ3 2024: 61MQ4 2024: 60MQ1 2025: 57MQ2 2025: 57MQ3 2025: 58MQ4 2025: 55MQ1 2026: 55MQ2 2026: 53M
Q3 2023: 61MQ4 2023: 62MQ1 2024: 62MQ2 2024: 61MQ3 2024: 61MQ4 2024: 60MQ1 2025: 57MQ2 2025: 57MQ3 2025: 58MQ4 2025: 55MQ1 2026: 55MQ2 2026: 53M
PeriodChange %Net change
Quarterly-2.8%-1.5M shares
1 year-6.9%-3.9M shares
3 years-14%-8.5M shares
5 years-15%-9.4M shares
Available history-18%-11.8M shares

MMS has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

MMS Net Leverage

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

MMS Weekly Momentum

MetricValueStatus
RSI55.9Neutral
Stochastic78.9Neutral

MMS's weekly RSI is 56 (neutral) and its Stochastic is 79 (neutral).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

MMS PE vs Industrials Sector

MetricMMSSector medianRelative
PE9.7x24x60% below
PE %75851 pts below

MMS is trading at 9.7x earnings, a 60% discount to the Industrials sector's median of 24x.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

MMS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$60.47.4% above
20 week MA$58.810% above
50 week MA$67.74.2% below
100 week MA$72.09.9% below
200 week MA$77.316% below

MMS has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 16% below its 200-week average.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB has the edge over MMS on trend strength, trading above more of its moving averages.

MMS Yearly ROI

YearStart priceEnd priceROI
2020$74.3$72.8-2%
2021$72.8$78.1+7.2%
2022$78.1$73.6-5.7%
2023$73.6$83.9+14%
2024$83.9$72.9-13%
2025$72.9$86.9+19%
2026 YTD$86.9$64.9-25%

MMS has finished lower in three of the last six years. It's down 25% so far in 2026.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB has the edge over MMS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key